KOLINPHARMA^® continues the economic takeover in the 2019 ranking of nutraceutical companies by sell-out generated by pharmacies and parapharmacies, ranking 76th compared to 84th place reached in 2018 and 111th in 2017 (source IQVIA).

In the first quarter of 2020, medical prescriptions, such as business performance indicators (KPI), recorded a growth of + 4% compared to the same period of the previous year. This result was achieved thanks to the implementation of the new commercial strategies that allowed doubledigit growth in January and February which more than compensated for the slowdown due to the containment measures put in place to combat the COVID-19 pandemic.